Effect of anti-tuberculosis treatment on thyroid profile in newly detected smear positive pulmonary tuberculosis cases
DOI:
https://doi.org/10.18203/2349-3933.ijam20182124Keywords:
Anti-tuberculosis treatment, Hypothyroidism, Thyroid stimulating hormoneAbstract
Background: Tuberculosis being a systemic disease and has a capacity for wide spread dissemination. Present study aims to identify the effects of antituberculous treatment on thyroid profile in new smear positive pulmonary tuberculosis cases.
Methods: This study was conducted among 60 new smear positive pulmonary tuberculosis cases attending pulmonary medicine OPD from May 2015 to April 2017. Thyroid function test in the form of free T3, free T4 and TSH was measured before initiating Anti tuberculosis treatment (ATT), at 3 months and at the end of 6 months.
Results: Out of 60 patients enrolled in present study, majority were males. Diabetes mellitus was the major co morbidity. Sick euthyroid was found to have decreasing trend during the course of treatment, and hypothyroidism was found to be increasing trend end of 6 months.
Conclusions: The common Thyroid Dysfunction seen during the study period was Hypothyroidism and Sick euthyroid. Anti-tuberculous medication preferably Rifampicin probably would explain the cause for these thyroid dysfunctions noticed during the study time. And those patients with significant hypothyroid need to started on thyroid supplements. Among the drugs used for treatment, rifampicin was probably the cause for thyroid dysfunction noticed during the course of treatment. Hence, authors recommend that these patients should be started on thyroid supplements after the diagnosis of significant hypothyroidism.
References
Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014 Mar;20(3):196-201.
Technical and Operational Guidelines for TB Control in India 2016: Central TB Division. [cited 2017 Oct 15]. Available at https://tbcindia.gov.in
Sharma SK, Mohan A editors. Tuberculosis. 2.ed., repr. New Delhi: Jaypee Brothers Medical Publishers; 2011:1052.
Aatif S, Qamar R, Imran IA and K. Sick euthyroid syndrome: thyroid function abnormalities in patients with non-thyroid illness. J Liaquat Univ Med Health Sci. 2008;7(2):83-6.
Lee S, Farwell AP. Euthyroid sick syndrome. Compr Physiol. 2016 Mar;6(2):1071-80.
Saharia GK, Ruram AA, Lyngwa J. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India. Indian J Tuberc. 2015 Jul;62(3):166-70.
Munivenkatappa S, Anil S, Naik B, Volkmann T, Sagili KD, Akshatha JS, et al. Drug-induced hypothyroidism during anti-tuberculosis treatment of multidrug-resistant tuberculosis: notes from the field. J Tuberc Res. 2016 Sep;4(3):105-10.
Chhabra N, Gupta N, Aseri ML, Mathur SK, Dixit R. Analysis of thyroid function tests in patients of multidrug resistance tuberculosis undergoing treatment. J Pharmacol Pharmacother. 2011;2(4):282-5.
Chow CC, Mak TW, Chan CH, Cockram CS. Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem. 1995 Jul;32(Pt 4):385-91.
Sajid KM, Parveen R, Sabih D-, Mahmood R. Thyroid function in pulmonary tuberculosis. JCPSP. 2006 Oct;16(10):633-6.
Rao S. Tuberculosis and patient gender: An analysis and its implications in tuberculosis control. Lung India Off Organ Indian Chest Soc. 2009;26(2):46-7.
Kim DL, Song KH, Lee JH, Lee KY, Kim SK. Rifampin-induced hypothyroidism without underlying thyroid disease. Thyroid Off J Am Thyroid Assoc. 2007 Aug;17(8):793-5.
Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009 Mar;1(1):18-28.
Jayaprakash KR. Cardiac involvement in patients with pulmonary tuberculosis. J Clin Diagn Res. 2011;53:440-2.
